Advertisement

International Journal of Hematology

, Volume 79, Issue 4, pp 354–357 | Cite as

Familial B-cell Chronic Lymphocytic Leukemia in a Population of Patients from Southern Italy

  • Silvana Capalbo
  • Vincenzo Callea
  • Caterina Musolino
  • Patrizia Guglielmo
  • Giovanni D’Arena
  • Alberto Fragasso
  • Cosima Battista
  • Rosario Giustolisi
  • Maura Brugiatelli
  • Vincenzo Lisoa
Article

Abstract

We investigated the prevalence of chronic lymphocytic leukemia (CLL) in 9650 relatives of 510 CLL patients from 5 different regions (Apulia, Basilicata, Campania, Calabria, and Sicily) of Southern Italy. Data collection included a family history questionnaire. In our series of 510 CLL patients, 53 families with 2 or more individuals who had chronic lymphoproliferative disease (CLD) or other hematological malignancies were identified. In these families, 27 cases of CLL, 10 of indolent non-Hodgkin’s lymphoma, and 7 of multiple myeloma were identified in relatives of CLL probands. Twenty-two relatives developed hematological malignancies other than CLD (19, acute leukemia; 3, chronic myeloid leukemia). In this study the prevalence of CLD in relatives of 510 CLL patients was 8.6% (44/510), and the prevalence of CLL in the same series was 5.2% (27/ 510). Considering the presence of clusters of individuals with hematological malignancies, overall our series contained 4 families showing a cluster with more than 2 cases. The most frequent pattern of affected family members was represented by 39 families (39/53 [73%]) with affected siblings or cousins only. Twenty siblings had CLL. The other families showed a multigenerational pattern with an affected parent-offspring relationship in only 11 (21%) of the cases and with a combination of the first 2 categories in 3 (6%) of the families. In 8 families belonging to both the last 2 mentioned groups, the affected offspring had an earlier disease onset than their parents, suggesting anticipation. We estimated the size and examined the pattern of familial aggregation of hematological malignancies, in particular CLL/CLD, in a specific geographical area. CLL was the most frequent disease in relatives, mainly siblings, of our CLL patients. Our results may be a contribution to the characterization of the epidemiological distribution pattern of CLL.

Key words

Familial B-cell chronic lymphocytic leukemia 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wendtner CM, Schmitt B, Bergmann M, Rohnisch T, Buhmann R, Hallek M. New aspects on the pathogenesis, diagnostic procedures, and therapeutic management of chronic lymphocytic leukemia.Int J Hematol. 2001;73:32–38.CrossRefPubMedGoogle Scholar
  2. 2.
    Linet MS, Blattner WA. The epidemiology of chronic lymphocytic leukemia. In: Polliack A, Catovsky D, eds.Chronic Lymphocytic Leukaemia Chur, Switzerland: Harwood Academic Publisher; 1988:11–32.Google Scholar
  3. 3.
    Pottern LM, Linet M, Blair A, et al. Familial cancer associated with subtypes of leukemia and non-Hodgkin’s lymphoma.Leuk Res. 1991;15:305–314.CrossRefPubMedGoogle Scholar
  4. 4.
    McPhedran P, Heath CW Jr, Lee J. Patterns of familial leukemia: ten cases of leukemia in two interrelated families.Cancer. 1969;24:403–407.CrossRefPubMedGoogle Scholar
  5. 5.
    Shpilberg O, Modan M, Modan B, Chetrit A, Fuchs Z, Ramot B. Familial aggregation of haematological neoplasms: a controlled study.Br J Haematol. 1994;87:75–80.CrossRefPubMedGoogle Scholar
  6. 6.
    Hakim I, Amariglio N, Brok-Simoni F, et al. Preferred usage of specific immunoglobulin gene segments in chronic lymphocytic leukaemia cells of three HLA-identical sisters.Br J Haematol. 1995;91:915–917.CrossRefPubMedGoogle Scholar
  7. 7.
    Fernhout F, Dinkelaar RB, Hagemeijer A, Groeneveld K, van Kammen E, van Dongen JJM. Four aged siblings with B cell chronic lymphocytic leukemia.Leukemia. 1997;11:2060–2065.CrossRefPubMedGoogle Scholar
  8. 8.
    Gunz FW, Gunz JP, Veale AMO, Chapman CJ, Houston IB. Familial leukaemia: a study of 909 families.Scand J Haematol. 1975;15:117–131.CrossRefPubMedGoogle Scholar
  9. 9.
    Cartwright RA, Bernard SM, Bird CC, et al. Chronic lymphocytic leukaemia: case control epidemiological study in Yorkshire.Br J Cancer. 1987;56:79–82.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Eriksson M, Bergström I. Familial malignant blood disease in the county of Jamtländ, Sweden.Eur J Haematol. 1987;38:241–245.CrossRefPubMedGoogle Scholar
  11. 11.
    Radovanovic Z, Markovic-Denic L, Jankovic S. Cancer mortality of family members of patients with chronic lymphocytic leukemia.Eur J Epidemiol. 1994;10:211–213.CrossRefPubMedGoogle Scholar
  12. 12.
    Cuttner J. Increased incidence of hematologic malignancies in first-degree relatives of patients with chronic lymphocytic leukemia.Cancer Invest. 1992;10:103–109.CrossRefPubMedGoogle Scholar
  13. 13.
    Goldgard DE, Easton DF, Cannon Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. JNatl Cancer Inst. 1994;86:1600–1608.CrossRefGoogle Scholar
  14. 14.
    Capalbo S, Trerotoli P, Ciancio A, Battista C, Serio G, Liso V. Increased risk of lymphoproliferative disorders in relatives of patients with B-cell chronic lymphocytic leukemia: relevance of the degree of familial linkage.Eur J Haematol. 2000;65:114–117.CrossRefGoogle Scholar
  15. 15.
    Cheson BD, Bennet JM, Grever M, et al. National Cancer Institute—sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment.Blood. 1996;87:4990–4997.Google Scholar
  16. 16.
    Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia.Blood. 1975;46:219–234.Google Scholar
  17. 17.
    Binet JL, Auquier A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis.Cancer. 1981;48:198–206.CrossRefGoogle Scholar
  18. 18.
    Zanetti R, Gafà L, Panelli F et al, eds: Ilcancro in Italia: I dati di incidenza dei Registri Tumori Vol. 3: 1983-1998. Lega Italiana per la lotta contro i Tumori. Associazione Italiana Registri Tumori. Roma: Il Pensiero Scientifico Editore; 2002.Google Scholar
  19. 19.
    Yuille MR, Matutes E, Marossy A, Hilditch B, Catovsky D, Houlston RS. Familial chronic lymphocytic leukaemia: a survey and review of published studies.Br J Haematol. 2000;109:794–799.CrossRefGoogle Scholar
  20. 20.
    Catovsky D. The search for genetic clues in chronic lymphocytic leukemia.Haematol Cell Ther. 1997;39:S5-S11.CrossRefGoogle Scholar
  21. 21.
    Horwitz M. The genetics of familial leukemia.Leukemia. 1997;11:1347–1359.CrossRefPubMedGoogle Scholar
  22. 22.
    Tamura K, Sawada H, Izumi Y, et al. Chronic lymphocytic leukemia (CLL) is rare, but the proportion of T-CLL is high in Japan. Kyushu Hematology Organization for Treatment (K-HOT) Study Group.Eur J Haematol. 2001;67:152–157.CrossRefPubMedGoogle Scholar
  23. 23.
    Boggs DR, Chen SC, Zhang ZN, Zhang A. Chronic lymphocytic leukemia in China.Am J Hematol. 1987;25:349–354.CrossRefPubMedGoogle Scholar
  24. 24.
    Weiss NS. Geographical variation in the incidence of the leukemias and lymphomas.Natl Cancer Inst Monogr. 1979;53:139–142.Google Scholar
  25. 25.
    Rawstron AC, Yuille MR, Fuller J, et al. Inherited predisposition to CLL is detectable as sub-clinical monoclonal B-lymphocyte expansion.Blood. 2002;100:2289–2290.CrossRefPubMedGoogle Scholar
  26. 26.
    Horwitz M, Goode EL, Jarvik GP. Anticipation in familial leukemia.Am J Hum Genet. 1996;59:990–998.PubMedPubMedCentralGoogle Scholar
  27. 27.
    Catovsky D. Familial chronic lymphocytic leukemia.Haematologica. 2002;87(suppl 2–10):3–4.Google Scholar
  28. 28.
    Yuille MR, Houlston RS, Catovsky D. Anticipation in familial chronic lymphocytic leukaemia.Leukemia. 1998;12:1696–1698.CrossRefPubMedGoogle Scholar
  29. 29.
    Goldin LR, Sgambati M, Marti GE, Fontaine L, Ishibe N. Anticipation in familial chronic lymphocytic leukemia.Am J Hum Genet. 1999;65:265–269.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Zent CS, Kyasa MJ, Evans R, Schichman SA. Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry data.Cancer. 2001;92:1325–1330.CrossRefPubMedGoogle Scholar
  31. 31.
    Ishibe N, Sgambati MT, Fontaine L, et al. Clinical characteristics of familial B-CLL in the National Cancer Institute Familial Registry.Leuk Lymphoma. 2001;42:99–108.CrossRefPubMedGoogle Scholar
  32. 32.
    Nair CN, Chougule A, Dhond S, et al. Trisomy 12 in chronic lymphocytic leukemia: geographical variation.Leuk Res. 1998;22:313–317.CrossRefPubMedGoogle Scholar
  33. 33.
    Bevan S, Catovsky D, Matutes E, et al. Linkage analysis for ATM in familial chronic lymphocytic leukaemia.Leukemia. 1999;13:1497–1500.CrossRefPubMedGoogle Scholar
  34. 34.
    Bevan S, Catovsky D, Matutes E, et al. Linkage analysis for major histocompatibility complex-related genetic susceptibility in familial chronic lymphocytic leukemia.Blood. 2000;96:3982–3984.PubMedGoogle Scholar
  35. 35.
    Payelle Brogard B, Magnac C, Mauro FR, Mandelli F, Dighiero G. Analysis of the B-cell receptor B29 (CD79B) gene in familial chronic lymphocytic leukemia.Blood. 1999;10:3516–3522.Google Scholar
  36. 36.
    Pritsch O, Troussard X, Magnac C, et al. VH gene usage by family members affected with chronic lymphocytic leukaemia.Br J Haematol. 1999;107:612–624.CrossRefGoogle Scholar
  37. 37.
    Sakai A, Marti GE, Caporaso N, et al. Analysis of expressed immunoglobulin heavy chain genes in familial B-CLL.Blood. 2000;95:1413–1419.Google Scholar

Copyright information

© The Japanese Society of Hematology 2004

Authors and Affiliations

  • Silvana Capalbo
    • 1
  • Vincenzo Callea
    • 2
  • Caterina Musolino
    • 3
  • Patrizia Guglielmo
    • 4
  • Giovanni D’Arena
    • 5
    • 6
  • Alberto Fragasso
    • 7
  • Cosima Battista
    • 1
  • Rosario Giustolisi
    • 4
  • Maura Brugiatelli
    • 2
    • 8
  • Vincenzo Lisoa
    • 1
  1. 1.HematologyUniversity of BariBariItaly
  2. 2.Division of HematologyAzienda Ospedaliera Bianchi Melacrino MorelliReggio CalabriaItaly
  3. 3.HematologyUniversity of MessinaMessinaItaly
  4. 4.HematologyUniversity of CataniaCataniaItaly
  5. 5.Division of HematologyAzienda Ospedaliera San Giovanni di Dio—Ruggi D’AragonaSalernoItaly
  6. 6.Division of Hematology and OncologyOspedale OncologicoRionero in VultureItaly
  7. 7.Division of Internal MedicinePresidio OspedalieroMateraItaly
  8. 8.HematologyAzienda Ospedaliera PapardoMessinaItaly

Personalised recommendations